Physician profile
Janet R Wright
NPI 1649234105
$1,767.51
in general payments reported to CMS, 2019-2025
17 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $417 · 2023: $114 · 2024: $549 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $435.14 | 2021-2025 | Injectafer |
| Abbvie INC. | $328.85 | 2021-2025 | |
| Astellas Pharma US INC | $200.52 | 2022-2025 | Veozah |
| Pfizer INC. | $178.21 | 2024-2025 | |
| Glaxosmithkline, LLC. | $124.00 | 2022 | |
| Novo Nordisk INC | $119.47 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $104.32 | 2021-2025 | Evenity, Prolia |
| Biohaven Pharmaceutical Holding Company Ltd. | $48.65 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.58 | 2021-2022 | |
| Lilly USA, LLC | $42.29 | 2023-2025 | Mounjaro, Zepbound |
| Organon LLC | $31.61 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $24.74 | 2025 | Thinprep 2000 Processor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.98 | 2023 | Jardiance |
| Pharmacosmos Therapeutics INC. | $20.45 | 2024 | Monoferric |
| Actelion Pharmaceuticals US, INC. | $16.06 | 2024 | Uptravi, Opsumit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $15.13 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $13.51 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.